ETUDE GENETIQUE ET PHYSIOLOGIQUE DES MUTANTS ARN POLYMERASE RIFAMPICINE-RESISTANTS D'ESCHERICHIA COLI K12. II. LOCALISATION DU LOCUS RIFAMPICINE SUR LA CARTE CHROMOSOMIQUE ET SA STRUCTURE FINEALIKHANYAN SI; TOVMASYAN KN.1973; GENETIKA; S.S.S.R.; DA. 1973; VOL. 9; NO 1; PP. 75-81; ABS. ANGL.; BIBL. 14 REF.Serial Issue

DNA-modified carbon paste electrode applied to the study of interaction between Rifampicin (RIF) and DNA in solution and at the electrode surfaceGIROUSI, S. Th; GHERGHI, I. Ch; KARAVA, M. K et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 4, pp 851-858, issn 0731-7085, 8 p.Article

Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapyADITYA, Nayak P; PATANKAR, Swati; MADHUSUDHAN, Basavaraj et al.Parasitology research (1987). 2010, Vol 106, Num 6, pp 1481-1484, issn 0932-0113, 4 p.Article

Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosis FDC products containing isoniazidMARIAPPAN, T. T; GEETHA, Thiraviam; PANDEY, Rajesh et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 3, pp 643-647, issn 0731-7085, 5 p.Article

Statistical evaluation of physiological variability of rifampicin in fixed dose combinationsPANCHAGNULA, Ramesh; PARMAR, Jitendra; KAUR, Kanwaljit et al.International journal of pharmaceutics. 2006, Vol 313, Num 1-2, pp 5-13, issn 0378-5173, 9 p.Article

Dissolution test as a surrogate for quality evaluation of rifampicin containing fixed dose combination formulationsAGRAWAL, Shrutidevi; PANCHAGNULA, Ramesh.International journal of pharmaceutics. 2004, Vol 287, Num 1-2, pp 97-112, issn 0378-5173, 16 p.Article

Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazoneMARIAPPAN, T. T; JINDAL, K. C; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 4, pp 905-908, issn 0731-7085, 4 p.Article

Plasmid-mediated rifampicin resistance in Pseudomonas fluorescensCHANDRASEKARAN, S; LALITHAKUMARI, D.Journal of medical microbiology. 1998, Vol 47, Num 3, pp 197-200, issn 0022-2615Article

Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicinNIEMI, Mikko; KIVISTÖ, Kari T; DICZFALUSY, Ulf et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 8, pp 565-568, issn 1744-6872, 4 p.Article

ETUDE GENETIQUE ET PHYSIOLOGIQUE DE MUTANTS D'ESCHERICHIA COLI K-12 A ARN POLYMERASE RESISTANTE A LA RIFAMPICINE. I. ETUDE DE QUELQUES CARACTERISTIQUES GENETIQUES ET PHENOTYPIQUES DES MUTANTS RIFAMPICINE RESISTANTS ET DE LEURS FORMES THERMOSENSIBLESALIKHANYAN SL; TOVMASYAN KN; SEVERINA IA et al.1972; GENETIKA; S.S.S.R.; DA. 1972; VOL. 8; NO 10; PP. 112-120; ABS. ANGL.; BIBL. 12 REF.Serial Issue

HYDROGENATION DERIVATIVES OF RIFAMPICIN; THEIR TRITIUM LABELLINGHANUS J; KOZEL J; BENES J et al.1979; COLLECT. CZECHOSL. CHEM. COMMUNIC.; CSK; DA. 1979; VOL. 44; NO 5; PP. 1671-1675; BIBL. 8 REF.Article

Biosynthetic origins of the oxygen atoms in the ansamycin antibiotics rifamycin B, O, and SANDERSON, M. G; MONYPENNY, D; RICKARDS, R. W et al.Journal of the Chemical Society. Chemical communications. 1989, Num 5, pp 311-313, issn 0022-4936, 3 p.Article

The dissolution and bioavailability of rifampicin products in healthy subjects and tubercular patientsSHINOZAWA, S; YOSHIMURA, A; ARAKI, Y et al.Research communications in chemical pathology and pharmacology. 1983, Vol 42, Num 1, pp 161-164, issn 0034-5164Article

DIFFERENTIAL EFFECTS OF RIFAMPICIN ON CULTURED HUMAN TUMOR CELLSWINTERS WD; TUAN AL; MORTON DL et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 12; PP. 3173-3179; BIBL. 20REF.Article

INTERSPECIFIC TRANSFORMATION OF RIFAMPICIN RESISTANCE IN THE GENUS BACILLUSHARFORD N; MERGEAY M.1973; MOLEC. GEN. GENET.; GERM.; DA. 1973; VOL. 120; NO 2; PP. 151-155; BIBL. 12REF.Serial Issue

RIBOSOME CRYSTALLIZATION WITHOUT HYPOTHERMIA IN CHORIOALLANTOIC MEMBRANES INFECTED WITH TYPE 2 HERPESVIRUS HOMINIS AND TREATED WITH RIFAMPICIN = CRISTALLISATION DES RIBOSOMES SANS HYPOTHERMIE DANS LES MEMBRANES CHORIOALLANTOIDIENNES INFECTEES PAR HERPESVIRUS HOMINIS TYPE 2 ET TRAITEES PAR LA RIFAMPICINEMORETTI GF; ZITELLI A; BARONI A et al.1972; J. SUBSMICR. CYTOL.; ITALY; DA. 1972; VOL. 4; NO 2; PP. 215-219; ABS. ITAL.; BIBL. 9REF.Serial Issue

In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistulaODERICH, Gustavo S; BOWER, Thomas C; HOFER, Jan et al.Journal of vascular surgery. 2011, Vol 53, Num 1, pp 99-106, issn 0741-5214, 8 p.Article

IMPLICATION OF RIFAMPICIN-QUINONE IN THE IRREVERSIBLE BINDING OF RIFAMPICIN TO MACROMOLECULESBOLT HM; REMMER H.1976; XENOBIOTICA; G.B.; DA. 1976; VOL. 6; NO 1; PP. 21-32; BIBL. 28 REF.Article

HRP-based biosensor for monitoring rifampicinALONSO LOMILLO, M. A; KAUFFMANN, J. M; ARCOS MARTINEZ, M. J et al.Biosensors & bioelectronics. 2003, Vol 18, Num 9, pp 1165-1171, issn 0956-5663, 7 p.Article

Reduction of false positives in prokaryotic mRNA differential displayNAGEL, A; FLEMING, J. T; SAYLER, G. S et al.BioTechniques. 1999, Vol 26, Num 4, pp 641-648, issn 0736-6205, 4 p.Article

MUTANTS RIFAMPICINE RESISTANTS CHEZ ESCHERICHIA COLI K12 STREPTOMYCINE DEPENDANTKALYAEVA EH S.1972; GENETIKA; S.S.S.R.; DA. 1972; VOL. 8; NO 10; PP. 96-104; ABS. ANGL.; BIBL. 13 REF.Serial Issue

RIFAMPICIN EFFECT ON TUBERCULIN HYPERSENSITIVITY AND HUMORAL ANTIBODY RESPONSE IN TUBERCULOUS GUINEA-PIGS = L'EFFET DE LA RIFAMPICINE SUR L'HYPERSENSIBILITE A LA TUBERCULINE ET LA REACTION DES ANTICORPS HUMORAUX CHEZ LE COBAYE TUBERCULEUXALGEORGE G; RUDESCU D.1973; Z. IMMUNITAETSFORSCH. EXPER. KLIN. IMMUNOL.; DTSCH.; DA. 1973; VOL. 144; NO 5; PP. 459-466; ABS. ALLEM. FR.; BIBL. 11REF.Serial Issue

Traitement de la brucellose humaine par la rifampicine = Treatment of human brucellosis with rifampinGODEAU, P; FUCHS, G; GUILLEVIN, L et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 1, pp 5-9, issn 0037-1777Article

Interaction of rifampin and digitoxinPOOR, D. M; SELF, T. H; DAVIS, H. L et al.Archives of internal medicine (1960). 1983, Vol 143, Num 3, issn 0003-9926, 599Article

Side-effects of antileprosy drugs in common useJOPLING, W. H.Leprosy review. 1983, Vol 54, Num 4, pp 261-270, issn 0305-7518Article